Pricing Reports

NICE INSIGHT REPORT

Microbial Fermentation, Biologics: 2024 Market Insight, CDMO Pricing and Competitor Benchmarking

Published July 2024
  • 2024 pricing data for benchmarking and informed decision-making
  • Pricing trends since 2019 and 2024 regional pricing breakdown (NA/EU/APAC)
  • 42 profiles of biologics CDMOs specializing in microbial fermentation
  • Pricing for 82 distinct line items
  • Clinical trial analysis of insulin and GLP-1 agonists, including top trial sponsors 
  • Analysis of trends and challenges in microbial-based biologics development and manufacturing
Learn More
Microbial Fermentation, Biologics

162 pages of primary market research to support your sales team and inform your business strategy, underpinned by exclusive feedback from interviews with some of the biologics sector’s most influential opinion leaders and decision makers.

Key market insights for innovators, CDMOs and investors in the biologics industry.

Essential CDMO market intelligence and pricing data

Unlock the biologics market with insights into manufacturing trends and a comprehensive study of the top CDMOs specializing in microbial fermentation of therapeutics. Benchmark your business from development to manufacture with our in-depth pricing studies, which use years of primary data.

 

Analysis of microbial fermentation-based biologics

Our Market Insight report provides unique analyses into biologics produced in microbial cell culture, such as cytokines and growth factors. Hear from PhD scientists, KOLs, and respected market voices discuss developing microbial fermentation-based biologics and the disruptive technologies forging the future of healthcare.